Improved fecal DNA test for colorectal cancer screening.

[1]  W. Chapman,et al.  CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer , 2006, Genes, chromosomes & cancer.

[2]  D. Ahlquist,et al.  A Sensitive Method to Quantify Human Long DNA in Stool: Relevance to Colorectal Cancer Screening , 2006, Cancer Epidemiology Biomarkers & Prevention.

[3]  C. Willett,et al.  Detection of stool DNA mutations before and after treatment of colorectal neoplasia , 2006, Cancer.

[4]  D. Lieberman,et al.  Utilization of colonoscopy in the United States: results from a national consortium. , 2005, Gastrointestinal endoscopy.

[5]  J. Olson,et al.  DNA Stabilization Is Critical for Maximizing Performance of Fecal DNA-Based Colorectal Cancer Tests , 2005, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[6]  L. Myeroff,et al.  Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. , 2005, Journal of the National Cancer Institute.

[7]  T. Heeren,et al.  Patient perceptions of stool-based DNA testing for colorectal cancer screening. , 2005, American journal of preventive medicine.

[8]  D. Ahlquist,et al.  Stool screening for colorectal cancer: molecular approaches. , 2005, Gastroenterology.

[9]  D. Ransohoff,et al.  Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. , 2004, The New England journal of medicine.

[10]  T. Levin,et al.  Colonoscopy capacity: Can we build it? Will they come? , 2004, Gastroenterology.

[11]  L. Seeff,et al.  Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? , 2004, Gastroenterology.

[12]  J. Issa,et al.  CpG island methylation in gastroenterologic neoplasia: a maturing field. , 2004, Gastroenterology.

[13]  L. Kann,et al.  Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test. , 2004, The Journal of molecular diagnostics : JMD.

[14]  M. Thun,et al.  Underuse of screening sigmoidoscopy and colonoscopy in a large cohort of US adults. , 2004, American journal of public health.

[15]  David F Ransohoff,et al.  Are Physicians Doing Too Much Colonoscopy? A National Survey of Colorectal Surveillance after Polypectomy , 2004, Annals of Internal Medicine.

[16]  A. Fendrick,et al.  Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. , 2004, Gastroenterology.

[17]  T. Church,et al.  Colorectal cancer screening adherence in a general population. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  C. Beeker,et al.  Colorectal Cancer Screening in Older Men and Women: Qualitative Research Findings and Implications for Intervention , 2000, Journal of Community Health.

[19]  J. Church,et al.  Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer , 2002, American Journal of Gastroenterology.

[20]  S. Thibodeau,et al.  Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. , 2000, Gastroenterology.

[21]  J. Herman,et al.  CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Vernon,et al.  Participation in colorectal cancer screening: a review. , 1997, Journal of the National Cancer Institute.

[23]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.